Journal of Immunotherapy · 2013 · 67 citations · 40 references
Life SciencesEndocrinologyImmunologyAutoimmunityImmunoregulationInflammationAutoimmune InflammationG Protein-coupled Receptor SignalingImmune SignalingRegulatory T CellsSteroid Hormone SignalingT Cell BiologyCd4 Positive T CellsCd4 T Cell ActivationEstrogen ImmunomodulationExperimental Autoimmune EncephalomyelitisImmunosuppressive CompoundsImmunosuppressive FunctionNaive T CellsTh17 Cell Differentiation
The transcription factor Foxp3 is critical to the suppressive phenotype of CD4+ regulatory T cells. Studies have clearly shown that numerous autoimmune diseases are marked by the presence of activated CD4+ T cells within the setting of chronic inflammation. Therefore, drugs capable of inducing Foxp3 expression in activated CD4+ T cells could be of great therapeutic interest. We have previously shown that the small molecule G-1, an agonist directed against the membrane-bound G protein-coupled estrogen receptor, can induce IL10 expression in naive CD4+ T cells. In addition, we and others have demonstrated that G-1 attenuates disease in an animal model of experimental autoimmune encephalomyelitis. Using ex vivo cultures of purified CD4+ T cells, we show that G-1 can elicit Foxp3 expression under TH17-polarizing conditions, which mimic the in situ inflammatory milieu of several autoimmune diseases. These findings build upon previous results demonstrating the immunosuppressive properties of the novel estrogenic small molecule G-1.
40
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
PubMed · 1997 · 66.6K citations
WanJun Chen, Wenwen Jin, Neil J. Hardegen et al. · The Journal of Experimental Medicine · 2003 · 4.6K citations · Full text
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Roli Khattri, Tom Cox, Sue-Ann Yasayko et al. · Nature Immunology · 2003 · 2.8K citations